Sundrug Co.,Ltd.
SDGCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $208 | $198 | $208 |
| % Growth | -99.3% | 4.8% | -4.7% | – |
| Cost of Goods Sold | $1 | $154 | $148 | $154 |
| Gross Profit | $0 | $53 | $51 | $54 |
| % Margin | 25.4% | 25.7% | 25.5% | 25.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $41 | $24 | $40 |
| Sales & Mktg Exp. | $0 | $0 | $24 | $0 |
| Other Operating Expenses | $0 | $0 | $17 | $0 |
| Operating Expenses | $0 | $41 | $41 | $40 |
| Operating Income | $0 | $12 | $10 | $14 |
| % Margin | 5.1% | 5.9% | 4.9% | 6.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $12 | $10 | $14 |
| Tax Expense | $0 | $4 | $3 | $4 |
| Net Income | $0 | $8 | $7 | $10 |
| % Margin | 3.5% | 3.8% | 3.5% | 4.6% |
| EPS | 0.42 | 67.92 | 59.16 | 81.73 |
| % Growth | -99.4% | 14.8% | -27.6% | – |
| EPS Diluted | 0.42 | 67.92 | 59.16 | 81.73 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $4 | $4 | $4 |
| EBITDA | $0 | $17 | $14 | $17 |
| % Margin | 7.2% | 8% | 7.1% | 8.4% |